Leslie A. Rivera Rosado

Author

Center for Drug Evaluation and Research

Also Known As

L. Rosado, Leslie A. Rivera Rosado, Leslie A.Rivera Rosado

Publications

572

Citations

H-Index

Concepts

All Affiliations

Center for Drug Evaluation and Research Johns Hopkins University Johns Hopkins Medicine United States Public Health Service Commissioned Officers Association Center for Biologics Evaluation and Research

About

Leslie A. Rivera Rosado is an author at Center for Drug Evaluation and Research specializing in cell biology, medicine, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	157
2	Cell Biology	5	5	157
3	Cellular Physiology	2	2	32
4	Immunology	2	2	72
5	Health Sciences	1	1	61

Leslie A. Rivera Rosado

Publications

465

Citations

H-Index

Page 1

	Year	Citations
Blockade of Rac1 Activity Induces G1 Cell Cycle Arrest or Apoptosis in Breast Cancer Cells through Downregulation of Cyclin D1, Survivin, and X-Linked Inhibitor of Apoptosis Protein Tatsushi Yoshida, Yaqin Zhang, Leslie A. Rivera Rosado, Molecular Cancer Therapeutics	2010	133
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5 Xu Di, Guofeng Zhang, Yaqin Zhang, Oncotarget	2013	80
Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling Yaqin Zhang, Leslie A. Rivera Rosado, Sun Young Moon, Journal of Biological Chemistry Jnk SignalingCell DeathCell ProliferationCancer BiologyTumor Biology	2009	61
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells Junjie Chen, Hui Shen, Leslie A. Rivera Rosado, Oncotarget	2012	56
Repeated Treatment with Subtoxic Doses of TRAIL Induces Resistance to Apoptosis through Its Death Receptors in MDA-MB-231 Breast Cancer Cells Tatsushi Yoshida, Yaqin Zhang, Leslie A. Rivera Rosado, Molecular Cancer Research Breast OncologyChemoprevention StrategySubtoxic DosesApoptosisImmunology	2009	52
RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression William P. Bozza, Yaqin Zhang, Kory Hallett, Oncotarget	2015	28
Association between α4 integrin cytoplasmic tail and non-muscle myosin IIA regulates cell migration Leslie A. Rivera Rosado, Troy A. Horn, Sara C. McGrath, Journal of Cell Science ImmunologyCytoskeletonCellular PhysiologyMuscle PhysiologyNon-muscle Myosin Iia	2011	20
The Use of a Stably Expressed FRET Biosensor for Determining the Potency of Cancer Drugs William P. Bozza, Xu Di, Kazuyo Takeda, PLoS ONE ApoptosisCell DeathBiosensing SystemsAnti-cancer AgentRadiation Oncology	2014	12
α<sub>4</sub>β<sub>1</sub>-Integrin regulates directionally persistent cell migration in response to shear flow stimulation Dustin Dikeman, Leslie A. Rivera Rosado, Troy A. Horn, American Journal of Physiology-Cell Physiology Cell AdhesionPersistent Cell MigrationCellular PhysiologyShear FlowFan Shape	2008	12
Comparability Considerations and Challenges for Expedited Development Programs for Biological Products Sarah J. Schrieber, Wendy S. Putnam, Edwin C.Y. Chow, Drugs in R&D	2020	11

Page 1